EcoDrugPlus

Ensembl ID : YDL134C
Description: -
211 Possible Orthologues:

Title

Ensembl ID : YDL136W
Description: -
86 Possible Orthologues:

Title

Ensembl ID : YDL147W
Description: -
73 Possible Orthologues:

Title

Ensembl ID : YDL155W
Description: -
265 Possible Orthologues:

Title

Ensembl ID : YDL168W
Description: -
152 Possible Orthologues:

Title

Ensembl ID : YDL188C
Description: -
211 Possible Orthologues:

Title

Ensembl ID : YDL191W
Description: -
86 Possible Orthologues:

Title

Ensembl ID : YDL243C
Description: -
800 Possible Orthologues:

Title

Ensembl ID : YDL246C
Description: -
155 Possible Orthologues:

Title

Ensembl ID : YDR012W
Description: -
116 Possible Orthologues:

Title

Ensembl ID : YDR025W
Description: -
107 Possible Orthologues:

Title

Ensembl ID : YDR038C
Description: -
461 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).